NSTK · 01.2026Independent supplement reference
NutriStack
Edition 1.0Updated August 1, 2026

Supplement × Prescription·Evidence index

Levodopa/Carbidopa and Vitamin B6: what the published research says

PubMed indexes 8 records that name Levodopa/Carbidopa and Vitamin B6 together, either in the title or in an interaction, co-administration, or pharmacokinetic context. Each one is listed below with its study design and, where the abstract states one, the authors’ own conclusion, quoted and linked. This page reports that literature. It does not tell you whether to combine them.

Read this first

An evidence index, not guidance.

Every statement below is attributed to a named, dated, linked source.

This page lists published research relevant to Levodopa/Carbidopa and Vitamin B6. It deliberately does not state whether the combination is safe, whether it interacts, in which direction, at what dose, or how far apart to take them.

The research

8 studies naming Levodopa/Carbidopa and Vitamin B6.

Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.

A Systematic Review to Identify Unacceptable Intake Levels of Vitamin B6 among Patients Taking Levodopa

Shokuhin eiseigaku zasshi. Journal of the Food Hygienic Society of Japan · 2017 · PMID 29311446

Meta-AnalysisSystematic ReviewHuman subjects

“Therefore, the acceptable intake of vitamin B6 for levodopa patients would be within the range of the recommended intake level, which is also within the usual range in foods in Japan, except for dietary supplements or health foods. Levodopa users should be cautious about taking dietary supplements and over-the-counter drugs.”

Sato et al. · From the abstract

Names both Levodopa/Carbidopa and Vitamin B6 in its title.

Refractory Seizures Secondary to Vitamin B6 Deficiency in Parkinson Disease: The Role of Carbidopa-Levodopa.

Case reports in neurology · 2022 · PMID 35949204

Case Reports

“Vitamin B6 is a required cofactor in the decarboxylation of levodopa to dopamine, and high levodopa dosages may cause B6 deficiency; in addition, carbidopa binds B6 irreversibly. We recommend screening of vitamin B6 levels in PD patients, especially those requiring high or increasing doses of carbidopa-levodopa and those with poor nutrition.”

Wise et al. · From the abstract

Names both Levodopa/Carbidopa and Vitamin B6 in its title.

Vitamin B6 Deficiency Anemia Attributed to Levodopa/Carbidopa Intestinal Gel Therapy for Parkinson's Disease: A Diagnostic Pitfall for Myelodysplastic Syndrome with Ring Sideroblasts.

Internal medicine (Tokyo, Japan) · 2022 · PMID 35569990

Case ReportsHuman subjects

“His anemia was promptly resolved with simple oral supplementation of pyridoxal phosphate hydrate. VB6 deficiency anemia can mimic myelodysplastic syndrome and thus is an important differential diagnosis for patients administered levodopa/carbidopa.”

Yasuda et al. · From the abstract

Names both Levodopa/Carbidopa and Vitamin B6 in its title.

Effect of chronic levodopa treatment on pyridoxine metabolism.

Neurology · 1975 · PMID 1167634

Comparative StudyHuman subjects

“Chronic administration of levodopa may result in an adaptive alteration in the decarboxylase system with an increased cellular ability to synthesize pyridoxal-5-phosphate from pyridoxine, possibly through enzyme induction. This metabolic alteration would protect against pyridoxine deficiency states and may explain in part the progressive loss of levodopa effectiveness sometimes observed.”

Mars · From the abstract

Names both Levodopa/Carbidopa and Vitamin B6 in its title.

Novel synthesis of a dual fluorimetric sensor for the simultaneous analysis of levodopa and pyridoxine.

Analytical and bioanalytical chemistry · 2021 · PMID 33106947

Human subjects

“The capability of the proposed fluorimetric sensor was investigated in human blood serum and urine samples. Graphical Abstract Schematic representation of nitrogen-doped carbon dots (NCDs), carbon dots from o-phenylenediamine (O-CDs), NCDs coated with imprinted polymers (NCD@MIPs), and O-CDs coated with imprinted polymers (O-CD@MIPs) in the presence and absence of levodopa and pyridoxine.”

Ghani et al. · From the abstract

Names both Levodopa/Carbidopa and Vitamin B6 in its title.

Vitamin B6 Deficiency in Patients With Parkinson Disease Treated With Levodopa/Carbidopa.

Clinical neuropharmacology · 2020 · PMID 32947426

Human subjects24 participants

“Vitamin B6 could play an important role in PD and its levels seem to be influenced by L-DOPA/CD. Plasma vitamin B6 levels should be monitored in patients receiving high L-DOPA/CD doses, especially those treated with intraduodenal infusion.”

Rojo-Sebastián et al. · Authors' conclusion

Names both Levodopa/Carbidopa and Vitamin B6 in its title.

The Parkinson's disease death rate: carbidopa and vitamin B6.

Clinical pharmacology : advances and applications · 2014 · PMID 25364278

Retracted Publication

“Carbidopa is postulated to contribute to the increasing Parkinson's disease death rate and to the classification of Parkinson's as a progressive neurodegenerative disease. It may contribute to L-dopa tachyphylaxis.”

Hinz et al. · From the abstract

Names both Levodopa/Carbidopa and Vitamin B6 in its title.

Limitations

What this evidence cannot tell you.

Search-based evidence indexes have real limits, and it is worth being explicit about them:

NutriStack

Track what you actually take.

NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Levodopa/Carbidopa, Vitamin B6, and several hundred other substances.

The checker is a research and organisation tool, not a clinical decision aid, and its per-pair assessments are excluded from search until they pass claim-level review.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.